These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1201 related articles for article (PubMed ID: 10433861)
21. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
22. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
23. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Chen L; Hoeger C; Rivier J; Fitzpatrick VD; Vandlen RL; Tashjian AH Biochem Biophys Res Commun; 1999 May; 258(3):689-94. PubMed ID: 10329447 [TBL] [Abstract][Full Text] [Related]
24. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773 [TBL] [Abstract][Full Text] [Related]
25. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Ozenberger BA; Hadcock JR Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136 [TBL] [Abstract][Full Text] [Related]
26. Somatostatin displayed on filamentous phage as a receptor-specific agonist. Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337 [TBL] [Abstract][Full Text] [Related]
27. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Reubi JC; Schaer JC; Waser B; Mengod G Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966 [TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and pharmacological characterization of a somatostatin receptor subtype in the gymnotiform fish Apteronotus albifrons. Zupanc GK; Siehler S; Jones EM; Seuwen K; Furuta H; Hoyer D; Yano H Gen Comp Endocrinol; 1999 Sep; 115(3):333-45. PubMed ID: 10480984 [TBL] [Abstract][Full Text] [Related]
29. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer]. Hofsli E Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977 [TBL] [Abstract][Full Text] [Related]
30. Activation of rat thymocytes selectively upregulates the expression of somatostatin receptor subtype-1. Sedqi M; Roy S; Mohanraj D; Ramakrishnan S; Loh HH Biochem Mol Biol Int; 1996 Feb; 38(1):103-12. PubMed ID: 8932524 [TBL] [Abstract][Full Text] [Related]
31. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis. Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Klisovic DD; O'Dorisio MS; Katz SE; Sall JW; Balster D; O'Dorisio TM; Craig E; Lubow M Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2193-201. PubMed ID: 11527930 [TBL] [Abstract][Full Text] [Related]
34. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806 [TBL] [Abstract][Full Text] [Related]
35. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859 [TBL] [Abstract][Full Text] [Related]
36. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation. Hadcock JR; Strnad J; Eppler CM Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728 [TBL] [Abstract][Full Text] [Related]
37. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225 [TBL] [Abstract][Full Text] [Related]
39. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010 [TBL] [Abstract][Full Text] [Related]
40. Molecular characterization and polymorphisms of the caprine Somatostatin (SST) and SST Receptor 1 (SSTR1) genes that are linked with growth traits. Jin QJ; Sun JJ; Fang XT; Zhang CL; Yang L; Chen DX; Shi XY; Du Y; Lan XY; Chen H Mol Biol Rep; 2011 Jun; 38(5):3129-35. PubMed ID: 20140708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]